The Creating and Restoring Equal Access to Equivalent Samples Act of 2017 aims to expedite the entry of lower-cost biosimilars and generics into the market.
Rachel B. Hardin, PharmD Candidate
Advertisement
Articles by Rachel B. Hardin, PharmD Candidate
Advertisement
Latest Updated Articles
Is CREATES a Solution to Rising Drug Costs?Published: February 22nd 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy
2
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
3
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms
4
Hormone Therapy Use, Understanding, and Perceptions Have Positively Shifted From 2021 to 2025
5
